Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Contact your GP if cravings accompany hypoglycaemia symptoms (trembling, sweating, confusion), interfere with dietary management or blood glucose control, or occur alongside concerning symptoms such as persistent abdominal pain or unexplained weight gain
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
GSH / GSSG
Cignas 2026 commercial formulary includes six GLP-1 medications: Wegovy (semaglutide for obesity and CVD), Zepbound (tirzepatide for obesity and OSA), Ozempic (semaglutide for type 2 diabetes), Mounjaro (tirzepatide for type 2 diabetes), Saxenda (liraglutide for obesity), and Rybelsus (oral semaglutide for type 2 diabetes)
US$ 20.99
US$ 25.09
US$ 28.74
US$ 20.05
US$ 28.54
US$ 25.49
